Arch Therapeutics Inc (ARTH)

[Polyphemus]

Lots of window dressing, but the emperor has no clothes (yet).

Most products in clinical use in US for pressure ulcers do not have to be stored in frozen state.

Chronic wound care products sell into a very price sensitive marketplace served by many competitive products. Market for these products is comprised of very different segments: hospitals, nursing homes and home care, with pricing determined by DRGs, Part B Medicare, and Part A Medicare respectively in these segments. Premium pricing is theoretically possible, though not at all likely. What's the basis for asserting that premium pricing is likely?